左心室の放出分子が保存された中等度の三回転の自然史の結果
Davide Margonato1, Michele Morosato2, Giacomo Ingallina2
1Cardiovascular Imaging Unit, Cardiothoracic Department, IRCCS San Raffaele Scientific Institute, Milan, Italy; Cardiovascular Imaging Research Center and Valve Science Center, Minneapolis Heart Institute and Foundation, Minneapolis, MN, USA.
International journal of cardiology
|August 27, 2025
まとめ
発射分子が保たれている中等度の三角吐症 (TR) の患者は,死亡と心不全の入院のリスクが大きい. 肺動脈の圧力が高くなると左側弁の状態が悪化します
科学分野:
- 心臓病科
- バルブ性心臓病
- エコカルディオグラフィー
背景:
- 左心室排泄分数 (LVEF) が保存され,左側弁性心臓病 (VHD) が発症しない中等度の三管吐 (TR) の自然経歴はよく定義されていません.
- この患者群でのアウトカムを理解することは,臨床管理にとって極めて重要です.
研究 の 目的:
- 中程度のTR,保存されたLVEF,および同時進行中の重度の左側VHDのない患者の長期的なアウトカムを評価する.
- 肺動脈シストリック圧力 (PASP) と同期する中等度の左側VHDを含む予後に影響を与える要因を特定する.
主な方法:
- 2012年から2020年の間に,中程度のTRを患った1198人のコホートが評価されました.
- 主なアウトカムは全原因による死亡であり,二次的なアウトカムは全原因による死亡と心不全 (HF) の入院の複合であった.
- 分析では,PASPと中程度の左側VHDを考慮し,追跡期間の中央値は2. 9年であった.
主要な成果:
- 3年生存率は69%で,一般患者より著しく低かった (p < 0. 001).
- 複合的アウトカムによる3年生存率は63%でした.
- 高いPASPは 悪い予後と相関する. 隔離された中程度のTR患者の年間死亡率は8. 9%でした.
結論:
- LVEFが保存され,左側VHDが重症でない中等レベルのTR患者は,死亡リスクとHF入院のリスクが高い.
- PASP値の上昇などの要因を早期に特定し,管理することは,この集団における結果を改善するために重要です.
さらに関連する動画
関連する概念動画
01:20Mitral Regurgitation I: Introduction
55
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
55
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
52
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
52
01:15Aortic Regurgitation I: Introduction
36
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
36
01:23Mitral Regurgitation II: Clinical Features and Diagnostic Tests
50
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
50
01:22Mitral Stenosis I: Introduction
34
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
34
01:25Mitral Regurgitation III: Medical Management
28
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
28